Koyfin Home > Directory > Health Care > Aeglea Biothera > EBITDA

Aeglea Biothera EBITDA Chart (AGLE)

Aeglea Biothera annual/quarterly EBITDA from 2014 to 2020. EBITDA stands for earnings before interest, taxes, depreciation and amortization. EBITDA is one indicator of a company's financial performance and is used as a proxy for the earning potential of a business, although doing so can have drawbacks. EBITDA strips out the cost of debt capital and its tax effects by adding back interest and taxes to earnings.
  • Aeglea Biothera EBITDA for the quarter ending June 06, 2020 was $-21m a -3.29% increase of 1m year over year
  • Aeglea Biothera EBITDA for the last 12 months ending June 06, 2020 was $-84m a 12.74% decrease of -11m year over year
  • Aeglea Biothera Annual EBITDA for 2019 was $-80m a 43.48% decrease of -35m from 2018
  • Aeglea Biothera Annual EBITDA for 2018 was $-45m a 39.28% decrease of -18m from 2017
  • Aeglea Biothera Annual EBITDA for 2017 was $-27m a 20.61% decrease of -6m from 2016
Other Income Statement Metrics:
  • Aeglea Biothera Net Income for the quarter ending December 12, 2018 was $-15m a 45.50% decrease of -7m year over year
  • Aeglea Biothera Total Revenue for the quarter ending June 06, 2018 was $2m a 46.97% increase of 1m year over year
View Chart On Koyfin

Quarterly AGLE EBITDA Data

06/2020$-21m
03/2020$-19m
12/2019$-22m
09/2019$-22m
06/2019$-19m
03/2019$-18m
12/2018$-15m
09/2018$-12m
06/2018$-10m
03/2018$-8m

Annual AGLE EBITDA Data

2019$-80m
2018$-45m
2017$-27m
2016$-22m
2015$-11m
2014$-9m